{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:59:22Z","timestamp":1785898762137,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Variegate porphyria (VP) is an autosomal dominantly inherited hepatic porphyria. The genetic defect in the <jats:italic>PPOX<\/jats:italic> gene leads to a partial defect of protoporphyrinogen oxidase, the penultimate enzyme of heme biosynthesis. Affected individuals can develop cutaneous symptoms in sun-exposed areas of the skin and\/or neuropsychiatric acute attacks. The identification of the genetic defect in VP families is of crucial importance to detect the carrier status which allows counseling to prevent potentially life threatening neurovisceral attacks, usually triggered by factors such as certain drugs, alcohol or fasting.<\/jats:p>\n          <jats:p>In a total of 31 Swedish VP families sequence analysis had identified a genetic defect in 26. In the remaining five families an extended genetic investigation was necessary. After the development of a synthetic probe set, MLPA analysis to screen for single exon deletions\/duplications was performed.<\/jats:p>\n          <jats:p>We describe here, for the first time, two partial deletions within the <jats:italic>PPOX<\/jats:italic> gene detected by MLPA analysis. One deletion affects exon 5 and 6 (c.339-197_616+320del1099) and has been identified in four families, most probably after a founder effect. The other extends from exon 5 to exon 9 (c.339-350_987+229del2609) and was found in one family. We show that both deletions are mediated by <jats:italic>Alu<\/jats:italic> repeats.<\/jats:p>\n          <jats:p>Our findings emphasize the usefulness of MLPA analysis as a complement to <jats:italic>PPOX<\/jats:italic> gene sequencing analysis for comprehensive genetic diagnostics in patients with VP.<\/jats:p>","DOI":"10.1186\/1750-1172-8-13","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T23:14:21Z","timestamp":1358378061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Partial protoporphyrinogen oxidase (PPOX) gene deletions, due to different Alu-mediated mechanisms, identified by MLPA analysis in patients with variegate porphyria"],"prefix":"10.1186","volume":"8","author":[{"given":"Michela","family":"Barbaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire","family":"Kotaj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Floderus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC: Porphyrias. Lancet. 2010, 375: 924-937. 10.1016\/S0140-6736(09)61925-5.","journal-title":"Lancet"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2133.2004.06120.x","volume":"151","author":"RJ Hift","year":"2004","unstructured":"Hift RJ, Meissner D, Meissner PN: A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family. Br J Dermatol. 2004, 151: 465-471. 10.1111\/j.1365-2133.2004.06120.x.","journal-title":"Br J Dermatol"},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.ejhg.5200860","volume":"10","author":"M Von Und Zu Fraunberg","year":"2002","unstructured":"Von Und Zu Fraunberg M, Timonen K, Mustajoki P, Kauppinen R: Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. Eur J Hum Genet. 2002, 10: 649-657. 10.1038\/sj.ejhg.5200860.","journal-title":"Eur J Hum Genet"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1172\/JCI116348","volume":"91","author":"P Meissner","year":"1993","unstructured":"Meissner P, Adams P, Kirsch R: Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. J Clin Invest. 1993, 91: 1436-1444. 10.1172\/JCI116348.","journal-title":"J Clin Invest"},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1034\/j.1399-0004.2003.00116.x","volume":"64","author":"\u00c5 Wiman","year":"2003","unstructured":"Wiman \u00c5, Harper P, Floderus Y: Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish families with variegate porphyria. Clin Genet. 2003, 64: 122-130. 10.1034\/j.1399-0004.2003.00116.x.","journal-title":"Clin Genet"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.0306-5251.2007.02955.x","volume":"64","author":"S Thunell","year":"2007","unstructured":"Thunell S, Pomp E, Brun A: Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. Br J Clin Pharmacol. 2007, 64: 668-679. 10.1111\/j.0306-5251.2007.02955.x.","journal-title":"Br J Clin Pharmacol"},{"key":"493_CR7","unstructured":"The Drug Database for Acute Porphyria.http:\/\/www.drugs-porphyria.org,"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1523-1747.1998.00148.x","volume":"110","author":"J Frank","year":"1998","unstructured":"Frank J, McGrath J, Lam H, Graham RM, Hawk JL, Christiano AM: Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. J Invest Dermatol. 1998, 110: 452-455. 10.1046\/j.1523-1747.1998.00148.x.","journal-title":"J Invest Dermatol"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/mgme.2000.2975","volume":"69","author":"AV Corrigall","year":"2000","unstructured":"Corrigall AV, Hift RJ, Davids LM, Hancock V, Meissner D, Kirsch RE, Meissner PN: Homozygous variegate porphyria in South Africa: genotypic analysis in two cases. Mol Genet Metab. 2000, 69: 323-330. 10.1006\/mgme.2000.2975.","journal-title":"Mol Genet Metab"},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1046\/j.1523-1747.2001.01293.x","volume":"116","author":"R Kauppinen","year":"2001","unstructured":"Kauppinen R, Timonen K, Von Und Zu Fraunberg M, Laitinen E, Ahola H, Tenhunen R, Taketani S, Mustajoki P: Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect. J Invest Dermatol. 2001, 116: 610-613. 10.1046\/j.1523-1747.2001.01293.x.","journal-title":"J Invest Dermatol"},{"key":"493_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2144\/04373ST04","volume":"37","author":"RF Stern","year":"2004","unstructured":"Stern RF, Roberts RG, Mann K, Yau SC, Berg J, Ogilvie CM: Multiplex ligation-dependent probe amplification using a completely synthetic probe set. Biotechniques. 2004, 37: 399-405.","journal-title":"Biotechniques"},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-0004.2008.00980.x","volume":"73","author":"M Barbaro","year":"2008","unstructured":"Barbaro M, Cicognani A, Balsamo A, Lofgren A, Baldazzi L, Wedell A, Oscarson M: Gene dosage imbalances in patients with 46, XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis. Clin Genet. 2008, 73: 453-464. 10.1111\/j.1399-0004.2008.00980.x.","journal-title":"Clin Genet"},{"key":"493_CR13","unstructured":"The SNP Database.http:\/\/www.ncbi.nlm.nih.gov\/SNP\/,"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000, 15: 7-12. 10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N.","journal-title":"Hum Mutat"},{"key":"493_CR15","unstructured":"The Human Gene Mutation Database.http:\/\/www.hgmd.cf.ac.uk,"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/302586","volume":"65","author":"SD Whatley","year":"1999","unstructured":"Whatley SD, Puy H, Morgan RR, Robreau AM, Roberts AG, Nordmann Y, Elder GH, Deybach JC: Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet. 1999, 65: 984-994. 10.1086\/302586.","journal-title":"Am J Hum Genet"},{"key":"493_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/10665270050081478","volume":"7","author":"Z Zhang","year":"2000","unstructured":"Zhang Z, Schwartz S, Wagner L, Miller W: A greedy algorithm for aligning DNA sequences. J Comput Biol. 2000, 7: 203-214. 10.1089\/10665270050081478.","journal-title":"J Comput Biol"},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tig.2009.05.005","volume":"25","author":"F Zhang","year":"2009","unstructured":"Zhang F, Carvalho CM, Lupski JR: Complex human chromosomal and genomic rearrangements. Trends Genet. 2009, 25: 298-307. 10.1016\/j.tig.2009.05.005.","journal-title":"Trends Genet"},{"key":"493_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2011.09.008","volume":"147","author":"JR Lupski","year":"2011","unstructured":"Lupski JR, Belmont JW, Boerwinkle E, Gibbs RA: Clan genomics and the complex architecture of human disease. Cell. 2011, 147: 32-43. 10.1016\/j.cell.2011.09.008.","journal-title":"Cell"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/ng.399","volume":"41","author":"F Zhang","year":"2009","unstructured":"Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR: The DNA replication FoSTeS\/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet. 2009, 41: 849-853. 10.1038\/ng.399.","journal-title":"Nat Genet"},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mgme.1999.2864","volume":"67","author":"PL Deininger","year":"1999","unstructured":"Deininger PL, Batzer MA: Alu repeats and human disease. Mol Genet Metab. 1999, 67: 183-193. 10.1006\/mgme.1999.2864.","journal-title":"Mol Genet Metab"},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-004-1204-9","volume":"116","author":"CJ Shaw","year":"2005","unstructured":"Shaw CJ, Lupski JR: Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms. Hum Genet. 2005, 116: 1-7. 10.1007\/s00439-004-1204-9.","journal-title":"Hum Genet"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1101\/gr.158801","volume":"11","author":"JE Stenger","year":"2001","unstructured":"Stenger JE, Lobachev KS, Gordenin D, Darden TA, Jurka J, Resnick MA: Biased distribution of inverted and direct Alus in the human genome: implications for insertion, exclusion, and genome stability. Genome Res. 2001, 11: 12-27. 10.1101\/gr.158801.","journal-title":"Genome Res"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/bjc.1988.23","volume":"57","author":"R Kauppinen","year":"1988","unstructured":"Kauppinen R, Mustajoki P: Acute hepatic porphyria and hepatocellular carcinoma. Brit J Cancer. 1988, 57: 117-120. 10.1038\/bjc.1988.23.","journal-title":"Brit J Cancer"},{"key":"493_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0168-8278(00)80097-5","volume":"32","author":"C Andant","year":"2000","unstructured":"Andant C, Puy H, Bogard C, Faivre J, Soul\u00e9 JC, Nordmann Y, Deybach JC: Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol. 2000, 32: 933-939. 10.1016\/S0168-8278(00)80097-5.","journal-title":"J Hepatol"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2340\/00015555-0870","volume":"90","author":"X Schneider-Yin","year":"2010","unstructured":"Schneider-Yin X, van Tuyll , van Serooskerken AM, Tyblewski W, Poblete-Gutierrez P, Minder EI, Frank J: Hepatocellular carcinoma in variegate porphyria: a serious complication. Acta Derm Venereol. 2010, 90: 512-515. 10.2340\/00015555-0870.","journal-title":"Acta Derm Venereol"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2796.2010.02335.x","volume":"269","author":"E Innala","year":"2011","unstructured":"Innala E, Andersson C: Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med. 2011, 269: 538-545. 10.1111\/j.1365-2796.2010.02335.x.","journal-title":"J Intern Med"},{"key":"493_CR28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1373\/clinchem.2008.122564","volume":"55","author":"SD Whatley","year":"2009","unstructured":"Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN: Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem. 2009, 55: 1406-1414. 10.1373\/clinchem.2008.122564.","journal-title":"Clin Chem"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bcmd.2006.05.003","volume":"37","author":"E Di Pierro","year":"2006","unstructured":"Di Pierro E, Besana V, Moriondo V, Brancaleoni V, Tavazzi D, Casalgrandi G, Ventura P, Rocchi E, Cappellini MD: A large deletion on chromosome 11 in acute intermittent porphyria. Blood Cells Mol Dis. 2006, 37: 50-54. 10.1016\/j.bcmd.2006.05.003.","journal-title":"Blood Cells Mol Dis"},{"key":"493_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1399-0004.2011.01628.x","volume":"81","author":"M Barbaro","year":"2011","unstructured":"Barbaro M, Kotaj\u00e4rvi M, Harper P, Floderus Y: Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria. Clin Genet. 2011, 81: 249-256.","journal-title":"Clin Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-8-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:35:47Z","timestamp":1630532147000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-8-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-8-13","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,16]]},"assertion":[{"value":"28 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}